Skip to main content
SpringerLink
Log in

Endothelin (ET)-receptor antagonists have potential in the treatment of renal diseases,

  • Comment
  • Published:
Inpharma Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Endothelin (ET)-receptor antagonists have potential in the treatment of renal diseases,. Inpharma Wkly. 1100, 5 (1997). https://doi.org/10.1007/BF03315234

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03315234

Keywords

Search

Navigation